Cancer care is changing — as are the clinical tools, tests and the terms used to diagnose and predict its path and treatment.
Read more in this article from the Fred Hutch Cancer Center by ACE member Diana Mapes, featuring ACE member Ginny Mason.

Cancer care is changing — as are the clinical tools, tests and the terms used to diagnose and predict its path and treatment.
Read more in this article from the Fred Hutch Cancer Center by ACE member Diana Mapes, featuring ACE member Ginny Mason.


Many advocates want to publish their personal stories, but often aren’t always sure where to begin. My advice is to start with your “why.” Ask yourself: Why do I want to tell this story? Is it to educate others, encourage early screening, influence research, or help another patient feel less alone? Your purpose will help…

“Ending Dementia Stigma could Change its Trajectory: Cancer’s History Shows Why” highlights the impact of cancer advocates from the perspective of the slow progress in the world of dementia research. This article by Saskia Sivananthan recently appeared in The Conversation. “Cancer did not change its stigma entirely because it became curable. It became curable faster…

Cancer Research UK (CRUK) has prepared a toolkit to assist researchers in patient and public involvement (PPI), noting that PPI can improve the quality and relevance of the research, and help articulate its benefits for cancer patients and members of the public.

This is an excellent summary of many of the top cancer stories of 2025 from the staff at Cancer Today.

A recent article in MedPage Today discussed the effectiveness of crowdfunding campaigns in meeting the out-of-pocket costs of cancer patients. While well-intentioned, the campaigns raised less than 5% of the out of pocket costs. “Our findings have clinical implications,” the authors wrote. “Discussions of expected cancer treatment costs with the oncology care team have long…